Royal Bank Of Canada Tyra Biosciences, Inc. Transaction History
Royal Bank Of Canada
- $471 Billion
- Q3 2024
A detailed history of Royal Bank Of Canada transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 2,135 shares of TYRA stock, worth $30,872. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,135
Previous 1,917
11.37%
Holding current value
$30,872
Previous $30,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding TYRA
# of Institutions
99Shares Held
43.2MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$151 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$93.2 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$67.4 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$60.4 Million97.27% of portfolio
-
Nextech Invest Ag4.06MShares$58.6 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $607M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...